Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients

Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients

Introduction: No therapy has proven to be effective yet to reduce mortality and/or invasive mechanical ventilation (IMV) requirement in COVID-19. Tocilizumab (TCZ) in patients with severe COVID-19 could be an effective treatment. Methods: We conducted a retrospective case-control study in the Nord F...

Full description

Bibliographic Details
Main Authors: Timothée Klopfenstein, Souheil Zayet, Anne Lohse, Phillippe Selles, Hajer Zahra, N’dri Juliette Kadiane-Oussou, Lynda Toko, Pierre-Yves Royer, Jean-Charles Balblanc, Vincent Gendrin, Thierry Conrozier
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Tocilizumab
Mortality
Invasive mechanical ventilation
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220306536

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220306536

Similar Items